Quick Order Cart

Cat. No. ARG1227

NEXN Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

NEXN Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population of the Raji B lymphoblast line, featuring disruption of NEXN, an F-actin-binding protein that stabilizes actin filaments and links them to focal adhesions via interactions with vinculin and alpha-actinin. NEXN operates downstream of RhoA, Rac1, and integrin signaling, and its loss impairs actin cytoskeletal dynamics. This knockout model is ideal for studying NEXN's role in B lymphocyte adhesion, migration, and immune synapse formation, with direct applications in lymphoma biology and cytoskeleton-targeted drug screening. Representative assays include immunofluorescence for F-actin and vinculin, cell adhesion assays, and Transwell migration assays.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    NEXN

    Gene Identifier

    NCBI Gene ID 91624

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The NEXN Knockout Raji Polyclonal Cells represent a CRISPR/Cas9-mediated gene-disrupted polyclonal population derived from the human Raji B lymphoblast cell line, engineered for loss-of-function analysis of the NEXN (nexilin) gene. This polyclonal knockout cell population provides a powerful tool to dissect NEXN-dependent actin cytoskeleton regulation in a lymphoid background without the need for clonal isolation, enabling population-level functional studies.

The Raji cell line, originally established from an Epstein-Barr virus (EBV)-positive Burkitt’s lymphoma patient, serves as a well-characterized model of transformed B lymphocytes. These cells maintain key features of mature B cells, including the ability to form immune synapses, and are extensively utilized in lymphoma biology, immunology, and signal transduction research. Their continuous growth and genetic tractability make Raji cells an ideal host for CRISPR-based gene editing.

NEXN encodes an F-actin-binding protein that crosslinks and stabilizes filamentous actin, mediating focal adhesion maturation and cell migration. NEXN is regulated by the Rho GTPases RhoA and Rac1 downstream of integrin signaling and mechanical stress, and its transcription is controlled by the SRF/MRTF pathway. The protein directly interacts with F-actin, vinculin, and alpha-actinin, recruiting vinculin to adhesion sites and promoting actin stabilization. Key pathway components, including integrins, talin, RhoA, ROCK, mDia, vinculin, and F-actin, converge on NEXN to orchestrate cytoskeletal dynamics and adhesion complex assembly.

In the context of Raji B lymphocytes, disruption of NEXN impairs actin cytoskeleton organization, which is predicted to compromise immune synapse formation??a critical process for antigen recognition and signaling. Additionally, NEXN knockout likely attenuates integrin-mediated adhesion and migration, processes essential for lymphoma cell dissemination and microenvironment interactions. This polyclonal knockout model thus enables investigation of how NEXN-dependent actin regulation impacts B cell adhesion, motility, and immune synapse architecture, offering insights into lymphoma pathogenesis.

Typical applications include Western blotting for NEXN and actin, immunofluorescence staining of F-actin (phalloidin) and vinculin, cell adhesion assays, Transwell migration/invasion assays, flow cytometry for integrin expression, Rho GTPase activation assays, and immune synapse formation analyses. These cells are also suitable for drug screening campaigns targeting cytoskeletal pathways in lymphoma. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)